Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$40.85 - $77.67 $140,319 - $266,796
-3,435 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$114.09 - $145.51 $41,642 - $53,111
-365 Reduced 9.61%
3,435 $478,000
Q1 2019

May 10, 2019

BUY
$35.52 - $62.62 $134,976 - $237,956
3,800 New
3,800 $238,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $298M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.